Natural Product: NPC559378

Natural Product IDNPC559378
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2~{R},3~{R},4~{S},5~{R},6~{S})-6-[2-[3-[(2~{S},3~{S},4~{S},5~{R},6~{R})-6-carboxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-phenyl]-5-hydroxy-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
IUPAC Name (2~{R},3~{R},4~{S},5~{R},6~{S})-6-[2-[3-[(2~{S},3~{S},4~{S},5~{R},6~{R})-6-carboxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-phenyl]-5-hydroxy-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OPANBGHBBMSMQC-TYBBTENRSA-N
Standard InCHI InChI=1S/C27H26O18/c28-9-2-1-7(3-13(9)43-27-21(36)17(32)19(34)23(45-27)25(39)40)12-6-11(30)15-10(29)4-8(5-14(15)42-12)41-26-20(35)16(31)18(33)22(44-26)24(37)38/h1-6,16-23,26-29,31-36H,(H,37,38)(H,39,40)/t16-,17-,18+,19+,20+,21-,22+,23+,26+,27+/m0/s1
SMILES O=C(O)[C@@H]1O[C@@H](OC2=CC(C3=CC(=O)C4=C(O)C=C(O[C@@H]5O[C@@H](C(=O)O)[C@H](O)[C@H](O)[C@H]5O)C=C4O3)=CC=C2O)[C@@H](O)[C@@H](O)[C@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   638.11 Volume:   564.625
?
Van der Waals volume.
Dense:   1.13 LogP:   0.186
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.762
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -1.92
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   32.0
TPSA:   303.57
?
Topological Polar Surface Area.
H-Bond Acceptor:   18.0
H-Bond Donor:   10.0 Rings:   5.0
Heavy Atoms:   18.0

MedChem Properties

QED Drug-Likeness Score:   0.127 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.818 Fsp3:   0.37
MCE-18:   127.459
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.476 Fluc inhibitor:   0.34
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.915
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.888
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.374 Promiscuous compounds:   0.515

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.454 MDCK Permeability:   -5.038
Pgp-inhibitor:   0.0 Pgp-substrate:   0.962
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.309
20% Bioavailability (F20%):   0.143 30% Bioavailability (F30%):   0.62
50% Bioavailability (F50%):   0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.985
Plasma Protein Binding (PPB):   73.355% Volume Distribution (VD):   -0.235
Fu: 22.84%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.001
OATP1B3 inhibitor:   0.057 BCRP inhibitor:   0.011
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.368
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.917 Half-life (T1/2):  6.087

ADMET: Toxicity

hERG Blockers:  0.001 hERG Blockers (10um):  0.009
Human Hepatotoxicity (H-HT):  0.36 Drug-induced Liver Injury (DILI):  0.983
AMES Toxicity:  0.637 Rat Oral Acute Toxicity:  0.016
Maximum Recommended Daily Dose:  0.013 Skin Sensitization:  0.992
Carcinogencity:  0.004 Eye Corrosion:  0.0
Eye Irritation:  0.212 Respiratory Toxicity:  0.007
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.966
Hematotoxicity:  0.097 Drug-induced Nephrotoxicity:  0.784
Genotoxicity:  0.886 RPMI-8226 Immunitoxicity:  0.1
A549 Cytotoxicity:  0.022 Hek293 Cytotoxicity:  0.03
BCF:   0.144
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.63
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.272
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.336
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25135 Marchantia berteroana Species Marchantiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO25135 Marchantia berteroana Species Marchantiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC559378 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8421 Intermediate Similarity NPC282169
0.8421 Intermediate Similarity NPC20505
0.7848 Intermediate Similarity NPC608742
0.6988 Remote Similarity NPC43211
0.6988 Remote Similarity NPC601144
0.6667 Remote Similarity NPC237435
0.6552 Remote Similarity NPC600989
0.6512 Remote Similarity NPC311830
0.6395 Remote Similarity NPC115760
0.6279 Remote Similarity NPC135277
0.6279 Remote Similarity NPC210094
0.625 Remote Similarity NPC253685
0.6053 Remote Similarity NPC137062
0.6 Remote Similarity NPC229409
0.5977 Remote Similarity NPC101191
0.5957 Remote Similarity NPC64051
0.5843 Remote Similarity NPC610187
0.5814 Remote Similarity NPC19709
0.5747 Remote Similarity NPC189142
0.5747 Remote Similarity NPC77660
0.5698 Remote Similarity NPC331652
0.5632 Remote Similarity NPC39360
0.5632 Remote Similarity NPC29763
0.5632 Remote Similarity NPC210003
0.5625 Remote Similarity NPC46202
0.5495 Remote Similarity NPC601710
0.5444 Remote Similarity NPC27942
0.54 Remote Similarity NPC195257
0.5385 Remote Similarity NPC235260
0.5385 Remote Similarity NPC49344
0.5385 Remote Similarity NPC155763
0.5376 Remote Similarity NPC190003
0.5341 Remote Similarity NPC473043
0.5326 Remote Similarity NPC22832
0.5326 Remote Similarity NPC243930
0.5319 Remote Similarity NPC4390
0.5263 Remote Similarity NPC606546
0.5222 Remote Similarity NPC95090
0.5222 Remote Similarity NPC27408
0.5213 Remote Similarity NPC601586
0.5165 Remote Similarity NPC181712
0.5128 Remote Similarity NPC48479
0.5111 Remote Similarity NPC261866
0.5106 Remote Similarity NPC602805
0.5106 Remote Similarity NPC607707
0.5102 Remote Similarity NPC210073
0.5063 Remote Similarity NPC108406

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC559378 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6667 Remote Similarity NPD4338 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data